- Home
- HOWL vs MKTW Comparison
HOWL vs MKTW Comparison
Compare HOWL & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- MKTW
- Stock Information
- Founded
- HOWL 2017
- MKTW 1999
- Country
- HOWL United States
- MKTW United States
- Employees
- HOWL N/A
- MKTW N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- MKTW Computer Software: Prepackaged Software
- Sector
- HOWL Health Care
- MKTW Technology
- Exchange
- HOWL Nasdaq
- MKTW Nasdaq
- Market Cap
- HOWL 47.1M
- MKTW 48.2M
- IPO Year
- HOWL 2021
- MKTW N/A
- Fundamental
- Price
- HOWL $1.33
- MKTW $17.81
- Analyst Decision
- HOWL Strong Buy
- MKTW Hold
- Analyst Count
- HOWL 5
- MKTW 1
- Target Price
- HOWL $7.20
- MKTW $20.00
- AVG Volume (30 Days)
- HOWL 135.8K
- MKTW 13.9K
- Earning Date
- HOWL 11-06-2025
- MKTW 11-06-2025
- Dividend Yield
- HOWL N/A
- MKTW 4.48%
- EPS Growth
- HOWL N/A
- MKTW 59.71
- EPS
- HOWL N/A
- MKTW 2.83
- Revenue
- HOWL N/A
- MKTW $358,121,000.00
- Revenue This Year
- HOWL N/A
- MKTW N/A
- Revenue Next Year
- HOWL N/A
- MKTW N/A
- P/E Ratio
- HOWL N/A
- MKTW $6.30
- Revenue Growth
- HOWL N/A
- MKTW N/A
- 52 Week Low
- HOWL $0.60
- MKTW $9.08
- 52 Week High
- HOWL $4.18
- MKTW $21.74
- Technical
- Relative Strength Index (RSI)
- HOWL 52.75
- MKTW 45.07
- Support Level
- HOWL $1.29
- MKTW $17.70
- Resistance Level
- HOWL $1.40
- MKTW $18.08
- Average True Range (ATR)
- HOWL 0.07
- MKTW 0.43
- MACD
- HOWL 0.00
- MKTW -0.03
- Stochastic Oscillator
- HOWL 61.90
- MKTW 33.33
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.